Last participant has been randomized and dosed in the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP) The study size was expanded to 183 participants due to patient and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results